[PDF][PDF] BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes

P Boël, C Wildmann, ML Sensi, R Brasseur… - Immunity, 1995 - cell.com
P Boël, C Wildmann, ML Sensi, R Brasseur, JC Renauld, P Coulie, T Boon…
Immunity, 1995cell.com
Several tumor antigens are recognized by autologous cytolytic T lymphocytes (CTL) on
human melanoma MZ2-MEL. Some of them are encoded by genes MAGE-1 and MAGE-3,
which are not expressed in normal tissues except in testis. Here, we report the identification
of a new gene that codes for another of these antigens. This gene, named BAGE, codes for a
putative protein of 43 aa and seems to belong to a family of several genes. The antigen
recognized by the autologous CTL consists of BAGE-encoded peptide AARAVFLAL bound …
Summary
Several tumor antigens are recognized by autologous cytolytic T lymphocytes (CTL) on human melanoma MZ2-MEL. Some of them are encoded by genes MAGE-1 and MAGE-3, which are not expressed in normal tissues except in testis. Here, we report the identification of a new gene that codes for another of these antigens. This gene, named BAGE, codes for a putative protein of 43 aa and seems to belong to a family of several genes. The antigen recognized by the autologous CTL consists of BAGE-encoded peptide AARAVFLAL bound to an HLA-Cw* 1601 molecule. Gene BAGE is expressed in 22% of melanomas, 30% of infiltrating bladder carcinomas, 10% of mammary carcinomas, 8% of head and neck squamous cell carcinomas, and 6% of non-small cell lung carcinomas. Like the MAGE genes, it is silent in normal tissues with the exception of testis. Because of its tumor-specific expression, the BAGE-encoded antigen may prove useful for cancer immunotherapy.
cell.com